Mono-Methyl-Histone H3 (Lys36) Antibody

What is Mono-Methyl-Histone H3 (Lys36) and why is it significant in epigenetic research?

Mono-Methyl-Histone H3 (Lys36) represents histone H3 with a single methyl group attached to the lysine residue at position 36. This specific modification occurs on histone H3, one of the four core histones (H2A, H2B, H3, and H4) that make up the nucleosome core particle, which consists of 146 base pairs of DNA wrapped around an octamer of these histone proteins . The mono-methylation of H3K36 represents one of several possible methylation states at this residue, with di- and tri-methylation also possible through the action of specific histone methyltransferases. Histone methylation plays a crucial role in regulating gene expression by either strengthening or weakening the binding between histone tails and DNA, consequently affecting the accessibility of transcription factors and RNA polymerase to the genetic material . Mono-methylation of H3K36 specifically has been associated with the repression of multiple-copy transgenes, indicating its role in the maintenance of silent chromatin states . This modification provides a distinct regulatory mechanism from di- and tri-methylation at the same residue, highlighting the complexity and specificity of histone modifications in chromatin regulation. Understanding the dynamics of H3K36 mono-methylation offers valuable insights into fundamental epigenetic mechanisms controlling genome organization and function.

How does Mono-Methyl-Histone H3 (Lys36) differ functionally from di- and tri-methylation states?

Mono-Methyl-Histone H3 (Lys36) serves functionally distinct roles from its di- and tri-methylated counterparts, despite occurring at the same amino acid residue. Research has demonstrated that the Rpd3S histone deacetylase complex, a critical regulator of chromatin structure, can distinguish between different methylation states of H3K36, with gel shift assays revealing that H3K36me1 displays only background levels of binding to Rpd3S, similar to unmodified nucleosomes . In contrast, both H3K36me2 and H3K36me3 robustly bind to the Rpd3S complex, with H3K36me3 showing slightly higher affinity . This differential binding capacity suggests that the transition from mono- to di-methylation represents a critical functional threshold in the recruitment of chromatin modifying complexes. Studies in plants have shown that H3K36me1 is particularly associated with silent multiple-copy transgenes and depends on SET3p activity, while H3K36me3 is primarily detected in euchromatic genes . The functional distinction between these methylation states is further evidenced by their different roles in cellular processes, with H3K36me3 specifically involved in the DNA mismatch repair (MMR) pathway by serving as a docking site for the hMutSα (hMSH2-hMSH6) mismatch sensor complex through the PWWP domain of hMSH6 . These findings collectively demonstrate that the three methylation states of H3K36 are not simply progressive steps in a linear pathway but rather represent distinct functional modifications with specific roles in chromatin regulation.

What enzyme systems are responsible for establishing and removing H3K36 mono-methylation?

The establishment of Mono-Methyl-Histone H3 (Lys36) involves specific methyltransferases that vary across species, creating a complex enzymatic network for targeted histone modification. In yeast, the SET2 methyltransferase is known to catalyze H3K36 methylation, while in mammals, the NSD1 methyltransferase plays a significant role in this process . Research utilizing recombinant SET3p protein has demonstrated its ability to catalyze the mono-methylation of histone H3 at lysine 9, suggesting that SET-domain containing proteins may have similar catalytic activities for different lysine residues . These methyltransferases typically utilize S-adenosylmethionine (SAM) as a methyl donor, as evidenced by in vitro methylation assays that incorporate 14C-SAM to detect methylation activity . The enzymatic process of establishing mono-methylation is distinct from the mechanisms that lead to higher methylation states, with specific enzymes potentially specialized for catalyzing only mono-methylation or for progressive methylation to di- and tri-methylation states. The removal of methyl groups from histones is catalyzed by histone demethylases, though specific demethylases for H3K36me1 are less well-characterized than those for di- and tri-methylation states. The balance between these opposing enzymatic activities establishes the dynamic regulation of H3K36 mono-methylation levels in chromatin, which fluctuates in response to cellular processes such as the cell cycle and transcriptional activity. Understanding these enzyme systems provides insights into potential targets for epigenetic therapies and experimental manipulations of chromatin structure.

How can Mono-Methyl-Histone H3 (Lys36) antibodies be optimized for chromatin immunoprecipitation (ChIP) experiments?

Optimizing Mono-Methyl-Histone H3 (Lys36) antibodies for chromatin immunoprecipitation requires careful consideration of antibody specificity, protocol modifications, and experimental controls to ensure reliable detection of this specific histone modification. When selecting an antibody, researchers should prioritize those validated for ChIP applications with demonstrated specificity, such as those that have undergone rigorous cross-reactivity testing against other methylation states of H3K36 and potentially confounding histone modifications . The immunogen information provided by manufacturers, such as "a peptide containing mono-methylated lysine 36 of histone H3," offers insights into the specificity of the antibody . For optimal ChIP performance, researchers should consider modified formaldehyde crosslinking conditions, as overfixation may mask the H3K36me1 epitope, while insufficient fixation may not properly capture the chromatin-associated proteins. Sonication parameters should be carefully optimized to generate chromatin fragments of 200-500 bp, which balance efficient immunoprecipitation with sufficient resolution for downstream analysis. Pre-clearing the chromatin with protein A/G beads before adding the H3K36me1 antibody can significantly reduce background signal by removing non-specifically binding chromatin fragments. Including appropriate controls is crucial: a non-specific IgG control establishes background enrichment levels, while parallel ChIP with antibodies against total histone H3 helps normalize for nucleosome density variations across the genome, allowing for accurate quantification of H3K36me1 enrichment relative to total H3 occupancy. To validate antibody specificity within the ChIP experiment, researchers should include recovery of known positive and negative genomic regions for H3K36me1 enrichment as internal controls.

What are the most effective experimental approaches to study the interplay between H3K36me1 and other histone modifications?

Investigating the interplay between Mono-Methyl-Histone H3 (Lys36) and other histone modifications requires sophisticated experimental strategies that can reveal their spatial and functional relationships within the chromatin landscape. Sequential ChIP (Re-ChIP) represents one of the most powerful approaches for studying co-occurrence of modifications, where chromatin is first immunoprecipitated with an H3K36me1-specific antibody, followed by a second immunoprecipitation with antibodies against other modifications of interest, such as acetylation marks or other methylation states . This technique directly demonstrates whether two modifications co-exist on the same nucleosome populations. Mass spectrometry-based approaches offer complementary insights, particularly tandem mass spectrometry of isolated histones, which can quantitatively profile combinatorial patterns of modifications on the same histone tail . Researchers should consider employing methyl-lysine analog (MLA) technology, which enables the generation of homogeneously modified recombinant histones for in vitro biochemical assays, as demonstrated in studies examining differential binding of chromatin-associated factors to specifically modified nucleosomes . Genetic approaches using mutants with altered levels of specific histone modifications, such as those affecting SET domain-containing methyltransferases, provide in vivo systems to study the interdependence of different modifications, as evidenced by research showing that SET3p suppression affects H3K9me1 levels . High-resolution imaging techniques like super-resolution microscopy combined with proximity ligation assays can visualize the spatial relationships between H3K36me1 and other modifications within nuclear territories. Together, these complementary approaches provide a comprehensive understanding of how H3K36me1 functions within the broader context of the histone code.

What computational tools and bioinformatic approaches are recommended for analyzing genome-wide H3K36me1 distribution patterns?

Analyzing genome-wide Mono-Methyl-Histone H3 (Lys36) distribution patterns requires specialized computational tools that can process and interpret complex ChIP-seq data while accounting for the unique characteristics of this histone modification. For preprocessing raw sequencing data, tools like FastQC for quality control followed by Trimmomatic or Cutadapt for adapter trimming and quality filtering are essential first steps . Alignment of reads to the reference genome should be performed using algorithms optimized for ChIP-seq data, such as Bowtie2 or BWA, with parameters adjusted to account for the often broad distribution patterns of histone modifications. Peak calling for H3K36me1 requires algorithms designed for broad marks rather than sharp transcription factor binding sites, with MACS2 (using the --broad flag), SICER, or ChromHMM being particularly suitable for identifying enriched regions of this modification . Differential binding analysis between experimental conditions can be conducted using tools like DiffBind or MAnorm, which normalize for sequencing depth and account for biological replicates. For integration with other genomic features, the BEDTools suite and the R/Bioconductor packages like ChIPpeakAnno enable association of H3K36me1 patterns with gene bodies, transcription start sites, and other histone modifications. Visualization tools including the Integrative Genomics Viewer (IGV), UCSC Genome Browser, or custom tracks in R using packages like Gviz are essential for examining the distribution of H3K36me1 across genomic features . For higher-level analyses exploring the relationship between H3K36me1 and chromatin states, researchers should consider employing ChromHMM or Segway to perform unsupervised clustering of various histone marks, identifying chromatin states associated with H3K36me1 enrichment. These computational approaches collectively enable comprehensive characterization of H3K36me1 distribution patterns and their functional implications in genome regulation.

How should researchers validate the specificity of Mono-Methyl-Histone H3 (Lys36) antibodies?

Validating the specificity of Mono-Methyl-Histone H3 (Lys36) antibodies requires a multi-faceted approach to ensure reliable detection of this particular histone modification while excluding cross-reactivity with other similar epitopes. Peptide competition assays represent a critical first validation step, wherein pre-incubation of the antibody with excess mono-methylated H3K36 peptide should abolish signal detection, while pre-incubation with unmodified or differently methylated H3K36 peptides (di- or tri-methylated) should not affect antibody binding . Western blot analysis using recombinant histone H3 proteins modified to different methylation states at lysine 36 provides direct comparison of antibody reactivity, with a specific H3K36me1 antibody showing strong signal only for the mono-methylated form at the expected molecular weight of approximately 17 kDa . Researchers should also conduct immunoblotting on histone extracts from cell lines with genetic manipulation of methyltransferases known to affect H3K36 methylation levels, such as SET2 or NSD1 knockdown/knockout models, to confirm that the detected signal changes accordingly with the expected alteration in H3K36me1 abundance . Dot blot assays with synthetic peptides representing various histone modifications, particularly those with similar sequence contexts like H3K9me1 or H3K27me1, provide a direct assessment of potential cross-reactivity with related epitopes. For ChIP applications, sequential ChIP experiments where initial immunoprecipitation with the H3K36me1 antibody is followed by a second round using antibodies against di- or tri-methylated H3K36 should show minimal enrichment if the antibody is truly specific for the mono-methylated form. Mass spectrometry validation of immunoprecipitated histones can provide definitive confirmation of antibody specificity by enabling direct identification and quantification of the modifications present on the pulled-down histones.

What control experiments are essential when studying H3K36me1 in relation to gene expression?

Establishing rigorous control experiments is crucial when investigating the relationship between Mono-Methyl-Histone H3 (Lys36) and gene expression to ensure valid interpretation of results and exclude alternative explanations. Antibody validation controls must be implemented first, including western blot confirmation of specificity using recombinant histones with defined methylation states and peptide competition assays to verify the selectivity of the H3K36me1 antibody against related modifications . For ChIP-seq or ChIP-qPCR experiments correlating H3K36me1 with gene expression, researchers should include input controls (non-immunoprecipitated chromatin) to normalize for DNA amount and accessibility differences across genomic regions, as well as IgG controls to establish background enrichment levels . Parallel ChIP experiments targeting total histone H3 are essential to normalize H3K36me1 signals to nucleosome occupancy, ensuring that observed differences reflect actual enrichment rather than variations in nucleosome density across different genomic regions . Genetic validation using cells with altered methyltransferase activity, such as SET2 or NSD1 knockdown/knockout models, provides functional controls to demonstrate causality between enzyme activity, H3K36me1 levels, and gene expression changes . When examining temporal relationships between H3K36me1 and transcription, time-course experiments with transcriptional inhibitors (such as α-amanitin or actinomycin D) or inducible gene expression systems help distinguish whether H3K36me1 is a cause or consequence of transcriptional changes. To control for indirect effects, researchers should include experimentally matched cell populations at similar cell cycle stages, as histone modifications can fluctuate during cell cycle progression, particularly during DNA replication . Additionally, comparison with other methylation states (H3K36me2 and H3K36me3) provides important context for understanding the specific contribution of mono-methylation, as demonstrated by studies showing distinct functional roles for different methylation states of the same residue .

How should researchers address inconsistent or contradictory results when analyzing H3K36me1 distribution across different cell types?

Inconsistent or contradictory results regarding Mono-Methyl-Histone H3 (Lys36) distribution across different cell types often stem from technical and biological variables that require systematic investigation to resolve. Antibody batch variability represents a primary technical factor, as different lots of the same antibody can exhibit varying specificities and sensitivities; researchers should therefore validate each new antibody lot using peptide arrays or dot blots with mono-, di-, and tri-methylated H3K36 peptides to confirm consistent specificity . Crosslinking efficiency variations between different cell types can dramatically affect epitope accessibility and ChIP efficiency, necessitating optimization of crosslinking conditions (time, formaldehyde concentration, temperature) for each cell type rather than applying a standardized protocol . Cell cycle synchronization is critical since histone methylation patterns fluctuate during cell cycle progression, with studies showing that H3K36 methylation levels change significantly between G1/S and G2/M phases; contradictory results may simply reflect analysis of cell populations at different cell cycle stages . The presence of cell type-specific methyltransferases and demethylases with varying expression levels and activities can establish divergent baseline patterns of H3K36me1, requiring characterization of the enzymes relevant to H3K36 methylation in each cell type under study . When comparing published datasets, researchers should carefully evaluate differences in experimental protocols, computational analysis pipelines, and normalization methods, as these technical factors can produce apparently contradictory results even when the underlying biology is consistent. To systematically address these issues, researchers should implement multi-layered validation strategies, including orthogonal detection methods (e.g., mass spectrometry validation of ChIP-seq results), multiple antibodies targeting the same modification, and genetic manipulation of relevant enzymes to confirm the specificity of observed patterns in each cell type . This comprehensive approach helps distinguish true biological differences in H3K36me1 distribution from technical artifacts.

What are the most common technical pitfalls in H3K36me1 detection and how can they be overcome?

Detection of Mono-Methyl-Histone H3 (Lys36) faces several technical challenges that can compromise experimental results, but these can be addressed through careful methodological refinements. Antibody cross-reactivity with similar histone modifications, particularly other mono-methylated lysine residues on histone H3 (such as H3K4me1, H3K9me1, or H3K27me1), represents one of the most prevalent issues; researchers should rigorously validate antibody specificity using peptide competition assays and dot blots with an array of modified histone peptides . Epitope masking due to protein-protein interactions or adjacent modifications can prevent antibody access to H3K36me1, especially in compacted chromatin regions; this can be mitigated by optimizing chromatin fragmentation conditions (sonication time and intensity) and employing dual crosslinking approaches or native ChIP for certain applications . Variability in extraction efficiency between different histone modifications can lead to misinterpretation of relative abundance; standardizing extraction protocols and including spike-in controls of recombinant histones with known modification levels allows for more accurate quantification . Signal-to-noise issues often plague H3K36me1 detection due to the relatively low abundance of this modification compared to H3K36me2/3 in some cell types; increasing antibody specificity through affinity purification against the specific antigen or using blocking peptides for related modifications can improve detection sensitivity . Batch effects in ChIP-seq or western blot experiments can introduce artificial variations; implementing technical replicates, using consistent lot numbers of antibodies, and processing experimental and control samples in parallel can minimize these effects . Inefficient ChIP due to suboptimal antibody binding conditions can be addressed by careful optimization of antibody concentration, incubation time and temperature, and buffer conditions (salt concentration, detergent type and concentration, pH) . By systematically addressing these technical pitfalls, researchers can substantially improve the reliability and reproducibility of H3K36me1 detection across different experimental platforms.

How can researchers differentiate between direct and indirect effects when studying the functional impact of H3K36me1?

Distinguishing direct from indirect effects in Mono-Methyl-Histone H3 (Lys36) functional studies requires sophisticated experimental designs that establish causality and mechanistic links. Rapid induction systems utilizing technologies like the auxin-inducible degron (AID) system to target H3K36 methyltransferases allow researchers to observe immediate consequences of depleting these enzymes before secondary effects accumulate; temporal analysis of H3K36me1 loss followed by transcriptional or chromatin structural changes can help establish the order of events and causal relationships . In vitro reconstitution experiments using recombinant or chemically modified histones with defined methylation states, such as those employing methyl-lysine analog technology, provide controlled systems to directly test protein-modification interactions without cellular complexity; these approaches have successfully demonstrated the differential binding of chromatin regulatory complexes like Rpd3S to specifically modified nucleosomes . Tethering experiments, where methyltransferases or demethylases specific to H3K36 are artificially recruited to defined genomic loci using systems like dCas9-enzyme fusions, allow researchers to induce local changes in H3K36me1 levels and observe the direct consequences at specific target genes without affecting global histone modification patterns . Domain-specific mutations in reader proteins that specifically disrupt their interaction with H3K36me1 while preserving other functions can help isolate the contribution of this particular recognition event to downstream processes, similar to studies on PWWP domains that recognize methylated H3K36 . Systematic multi-omics approaches combining ChIP-seq for H3K36me1, RNA-seq for transcriptional effects, and proteomics for identifying bound factors provide correlative evidence across multiple levels that strengthen causal inferences when temporal relationships are established. These complementary approaches collectively enable researchers to build strong mechanistic models distinguishing the direct functions of H3K36me1 from secondary consequences, establishing its specific role within the complex regulatory network of histone modifications.

How is H3K36me1 involved in DNA damage repair processes compared to other methylation states?

The role of Mono-Methyl-Histone H3 (Lys36) in DNA damage repair appears distinct from its di- and tri-methylated counterparts, with emerging evidence suggesting specialized functions in chromatin organization during repair processes. While H3K36me3 has been well-characterized as a docking site for the DNA mismatch repair (MMR) machinery, particularly the hMutSα (hMSH2-hMSH6) complex through interaction with the PWWP domain of hMSH6, the specific contribution of H3K36me1 to repair pathways remains less defined . Research suggests that H3K36me1 may be involved in the initial chromatin response to DNA damage, potentially participating in chromatin decompaction to facilitate access of repair factors to damaged sites. The differential binding properties of H3K36 methylation states to chromatin regulators are significant, as demonstrated by studies showing that the Rpd3S histone deacetylase complex selectively binds to di- and tri-methylated H3K36 but not the mono-methylated form, suggesting that H3K36me1 might recruit a distinct set of repair-associated proteins . Cancer-associated mutations affecting histone H3, particularly those at glycine 34 (H3G34) which lies in proximity to K36, disrupt the normal methylation pattern at K36 and impair mismatch repair, highlighting the critical role of properly regulated H3K36 methylation in maintaining genome stability . The dynamic regulation of H3K36 methylation states during the cell cycle, with fluctuations observed particularly during the DNA replication phase, suggests a coordinated role in coupling repair processes to cell cycle progression . Further investigation using site-specific induction of DNA damage, coupled with temporal monitoring of H3K36 methylation states and repair factor recruitment, will be essential to fully elucidate the specific contribution of H3K36me1 to different DNA repair pathways and its mechanistic distinction from other methylation states.

What emerging techniques are advancing our understanding of H3K36me1 dynamics in living cells?

Cutting-edge methodologies are revolutionizing our ability to study Mono-Methyl-Histone H3 (Lys36) dynamics with unprecedented temporal and spatial resolution in living cellular systems. Live-cell imaging of H3K36me1 has been advanced through the development of recombinant antibody-derived probes such as mintbodies (modification-specific intracellular antibodies) or nanobodies fused to fluorescent proteins, enabling real-time visualization of this modification's distribution and dynamics during processes like cell division or transcriptional activation . CRISPR-based epigenome editing systems, where catalytically inactive Cas9 (dCas9) is fused to specific methyltransferases or demethylases, allow researchers to precisely manipulate H3K36me1 levels at defined genomic loci and observe the consequent effects on chromatin organization and gene expression in living cells . Single-molecule tracking technologies combined with site-specific incorporation of fluorescently labeled histones bearing defined modifications have enabled researchers to measure the kinetics of protein interactions with H3K36me1-containing nucleosomes in living cells, revealing the dynamic nature of these interactions . Mass spectrometry-based approaches have been refined to enable isotope labeling of newly synthesized histones (pulse-chase experiments), allowing quantitative measurement of H3K36me1 establishment and turnover rates during processes like DNA replication or transcriptional changes . Super-resolution microscopy techniques, including Structured Illumination Microscopy (SIM) and Stochastic Optical Reconstruction Microscopy (STORM), have improved spatial resolution of H3K36me1 distribution within the nucleus, revealing its organization into distinct chromatin domains that correlate with functional genomic states . Microfluidic approaches coupled with single-cell sequencing technologies now enable researchers to examine H3K36me1 distribution across individual cells within heterogeneous populations, revealing cell-to-cell variability in modification patterns that may contribute to divergent cellular behaviors or developmental trajectories. These technological advances collectively provide unprecedented insights into the dynamic nature of H3K36me1 in living cells, moving beyond static snapshots to understand how this modification integrates into the complex, temporally regulated processes of chromatin organization and genome function.